ID: PMRREP24595
Format: PPT*, PDF, EXCEL
Last Updated: 30 September 2022
Industry: IT and Telecommunication
Number of Pages: 190
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Market Background
3.1. Macroeconomic Factors
3.2. Forecast Factors: Relevance & Impact
3.3. Value Chain Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Challenge
3.4.3. Opportunity Analysis
4. Market Forecast
4.1. Market Size Projections
4.1.1. Y-o-Y Projections
4.1.2. Absolute $ Opportunity Analysis
5. Global Pharmacy Benefit Manager Market Analysis by Service
5.1. Introduction
5.1.1. Market Value Share Analysis by Service
5.1.2. Y-o-Y Growth Analysis by Service
5.2. Historical Market Size Analysis by Service, 2016-2021
5.3. Market Size Forecast by Service, 2022-2032
5.3.1. Retail Pharmacy Services
5.3.2. Specialty Pharmacy Services
5.3.3. Benefit Plan Design and Consultation
5.3.4. Drug Formulary Management
5.3.5. Other Services
5.4. Market Attractiveness Analysis by Service
6. Global Pharmacy Benefit Manager Market Analysis by Demand Determinant
6.1. Introduction
6.1.1. Market Value Share Analysis by Demand Determinant
6.1.2. Y-o-Y Growth Analysis by Demand Determinant
6.2. Historical Market Size Analysis by Demand Determinant, 2016-2021
6.3. Market Size Forecast by Demand Determinant, 2022-2032
6.3.1. Government Heath Programs
6.3.2. Employer-sponsored Programs
6.3.3. Health Insurance Management
6.3.4. Other Services
6.4. Market Attractiveness Analysis by Demand Determinant
7. Global Pharmacy Benefit Manager Market Analysis by Region
7.1. Introduction
7.1.1. Market Value Share Analysis by Region
7.1.2. Y-o-Y Growth Analysis by Region
7.2. Historical Market Size Analysis by Region, 2016-2021
7.3. Market Size Forecast by Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. SEA and Others of APAC
7.3.5. China
7.3.6. Japan
7.3.7. Middle East and Africa
7.4. Market Attractiveness Analysis by Region
8. North America Pharmacy Benefit Manager Market Analysis
8.1. Introduction
8.2. Historical Market Size Analysis by Market Segment, 2016-2021
8.3. Market Size Forecast by Market Segment, 2022-2032
8.3.1. By Country
8.3.1.1. U.S.
8.3.1.2. Canada
8.3.2. By Service
8.3.3. By Demand Determinant
8.4. Market Attractiveness Analysis
8.4.1. By Country
8.4.2. By Service
8.4.3. By Demand Determinant
8.5. Market Trend
8.6. Drivers and Restraints – Impact Analysis
9. Latin America Pharmacy Benefit Manager Market Analysis
9.1. Introduction
9.2. Historical Market Size Analysis by Market Segment, 2016-2021
9.3. Market Size Forecast by Market Segment, 2022-2032
9.3.1. By Country
9.3.1.1. Brazil
9.3.1.2. Mexico
9.3.1.3. Rest of Latin America
9.3.2. By Service
9.3.3. By Demand Determinant
9.4. Market Attractiveness Analysis
9.4.1. By Country
9.4.2. By Service
9.4.3. By Demand Determinant
9.5. Market Trend
9.6. Drivers and Restraints – Impact Analysis
10. Europe Pharmacy Benefit Manager Market Analysis
10.1. Introduction
10.2. Historical Market Size Analysis by Market Segment, 2016-2021
10.3. Market Size Forecast by Market Segment, 2022-2032
10.3.1. By Country
10.3.1.1. Germany
10.3.1.2. Italy
10.3.1.3. France
10.3.1.4. U.K.
10.3.1.5. Spain
10.3.1.6. Russia
10.3.1.7. Rest of Europe
10.3.2. By Service
10.3.3. By Demand Determinant
10.4. Market Attractiveness Analysis
10.4.1. By Country
10.4.2. By Service
10.4.3. By Demand Determinant
10.5. Market Trend
10.6. Drivers and Restraints – Impact Analysis
11. China Pharmacy Benefit Manager Market Analysis
11.1. Introduction
11.2. Historical Market Size Analysis by Market Segment, 2016-2021
11.3. Market Size Forecast by Market Segment, 2022-2032
11.3.1. By Service
11.3.2. By Demand Determinant
11.4. Market Attractiveness Analysis
11.4.1. By Service
11.4.2. By Demand Determinant
11.5. Market Trend
11.6. Drivers and Restraints – Impact Analysis
12. Japan Pharmacy Benefit Manager Market Analysis
12.1. Introduction
12.2. Historical Market Size Analysis by Market Segment, 2016-2021
12.3. Market Size Forecast by Market Segment, 2022-2032
12.3.1. By Service
12.3.2. By Demand Determinant
12.4. Market Attractiveness Analysis
12.4.1. By Service
12.4.2. By Demand Determinant
12.5. Market Trend
12.6. Drivers and Restraints – Impact Analysis
13. SEA and Others of APAC Pharmacy Benefit Manager Market Analysis
13.1. Introduction
13.2. Historical Market Size Analysis by Market Segment, 2016-2021
13.3. Market Size Forecast by Market Segment, 2022-2032
13.3.1. By Country
13.3.1.1. India
13.3.1.2. ASEAN
13.3.1.3. Australia and New Zealand
13.3.1.4. Rest of SEA and Others of APAC
13.3.2. By Service
13.3.3. By Demand Determinant
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Service
13.4.3. By Demand Determinant
13.5. Market Trend
13.6. Drivers and Restraints – Impact Analysis
14. Middle East & Africa Pharmacy Benefit Manager Market Analysis
14.1. Introduction
14.2. Historical Market Size Analysis by Market Segment, 2016-2021
14.3. Market Size Forecast by Market Segment, 2022-2032
14.3.1. By Country
14.3.1.1. Northern Africa
14.3.1.2. GCC Countries
14.3.1.3. South Africa
14.3.1.4. Turkey
14.3.1.5. Rest of Middle East and Africa
14.3.2. By Service
14.3.3. By Demand Determinant
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Service
14.4.3. By Demand Determinant
14.5. Market Trend
14.6. Drivers and Restraints – Impact Analysis
15. Market Structure Analysis
15.1. Market Analysis by Tier of Companies
15.1.1. By Large, Medium and Small
15.2. Market Concentration
15.2.1. By Top 5 and by Top 10
15.3. Market Share Analysis of Top 10 Players
16. Competition Analysis
16.1. Competition Dashboard
16.2. Competition Deep Dive
16.2.1. Express Scripts Holding Company
16.2.1.1. Overview
16.2.1.2. Product Portfolio
16.2.1.3. Sales Footprint
16.2.1.4. Channel Footprint
16.2.1.6. Strategy
16.2.1.6.1. Marketing Strategy
16.2.1.6.2. Product Strategy
16.2.1.6.3. Channel Strategy
16.2.2. CVS Health Corporation
16.2.2.1. Overview
16.2.2.2. Product Portfolio
16.2.2.3. Sales Footprint
16.2.2.4. Channel Footprint
16.2.2.6. Strategy
16.2.2.6.1. Marketing Strategy
16.2.2.6.2. Product Strategy
16.2.2.6.3. Channel Strategy
16.2.3. DST Systems, Inc.
16.2.3.1. Overview
16.2.3.2. Product Portfolio
16.2.3.3. Sales Footprint
16.2.3.4. Channel Footprint
16.2.3.6. Strategy
16.2.3.6.1. Marketing Strategy
16.2.3.6.2. Product Strategy
16.2.3.6.3. Channel Strategy
16.2.4. Rite Aid Corp.
16.2.4.1. Overview
16.2.4.2. Product Portfolio
16.2.4.3. Sales Footprint
16.2.4.4. Channel Footprint
16.2.4.6. Strategy
16.2.4.6.1. Marketing Strategy
16.2.4.6.2. Product Strategy
16.2.4.6.3. Channel Strategy
16.2.5. ProCare Rx.
16.2.5.1. Overview
16.2.5.2. Product Portfolio
16.2.5.3. Sales Footprint
16.2.5.4. Channel Footprint
16.2.5.6. Strategy
16.2.5.6.1. Marketing Strategy
16.2.5.6.2. Product Strategy
16.2.5.6.3. Channel Strategy
16.2.6. UnitedHealth Group
16.2.6.1. Overview
16.2.6.2. Product Portfolio
16.2.6.3. Sales Footprint
16.2.6.4. Channel Footprint
16.2.6.6. Strategy
16.2.6.6.1. Marketing Strategy
16.2.6.6.2. Product Strategy
16.2.6.6.3. Channel Strategy
16.2.7. Benecard Services, LLC
16.2.7.1. Overview
16.2.7.2. Product Portfolio
16.2.7.3. Sales Footprint
16.2.7.4. Channel Footprint
16.2.7.6. Strategy
16.2.7.6.1. Marketing Strategy
16.2.7.6.2. Product Strategy
16.2.7.6.3. Channel Strategy
16.2.8. BioScrip, Inc.
16.2.8.1. Overview
16.2.8.2. Product Portfolio
16.2.8.3. Sales Footprint
16.2.8.4. Channel Footprint
16.2.8.6. Strategy
16.2.8.6.1. Marketing Strategy
16.2.8.6.2. Product Strategy
16.2.8.6.3. Channel Strategy
16.2.9. CaptureRx
16.2.9.1. Overview
16.2.9.2. Product Portfolio
16.2.9.3. Sales Footprint
16.2.9.4. Channel Footprint
16.2.9.6. Strategy
16.2.9.6.1. Marketing Strategy
16.2.9.6.2. Product Strategy
16.2.9.6.3. Channel Strategy
16.2.10. Change Healthcare
16.2.10.1. Overview
16.2.10.2. Product Portfolio
16.2.10.3. Sales Footprint
16.2.10.4. Channel Footprint
16.2.10.6. Strategy
16.2.10.6.1. Marketing Strategy
16.2.10.6.2. Product Strategy
16.2.10.6.3. Channel Strategy
17. Research Methodology